Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simulations Plus (SLP)
NASDAQ:SLP
Holding SLP?
Track your performance easily
SLP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$27.22 - $51.22
Previous Close$32.15
Volume126.15K
Average Volume (3M)173.71K
Market Cap
$645.16M
Enterprise Value$625.91M
Total Cash (Recent Filing)$20.25M
Total Debt (Recent Filing)$1.01M
Price to Earnings (P/E)65.6
Beta1.33
Next Earnings
Jan 08, 2025EPS Estimate
$0.12Last Dividend Ex-Date
Jul 29, 2024Dividend Yield0.78%
Share Statistics
EPS (TTM)0.49
Shares Outstanding20,067,184
10 Day Avg. Volume199,921
30 Day Avg. Volume173,709
Standard Deviation0.14
R-Squared0.07
Alpha-0.00329
Financial Highlights & Ratios
Price to Book (P/B)3.51
Price to Sales (P/S)9.21
Price to Cash Flow (P/CF)96.90
P/FCF Ratio165.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.94
Enterprise Value/Gross Profit14.51
Enterprise Value/Ebitda37.82
Forecast
1Y Price Target
$57.00Price Target Upside78.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Simulations Plus News
PremiumCompany Announcements
Simulations Plus Reports 18% Revenue Increase for 2024Bulls Say, Bears Say
Bulls Say
Financial PerformanceSLP provided its initial FY25 revenue outlook of $90M-$93M, representing a 29% increase at the midpoint.
Growth PotentialSLP's growth potential combined with strong margin profile makes current valuation attractive.
Industry PositionThe Company is the second largest in the industry, focused on providing bio-simulation software, technology, and services to transform traditional drug discovery and development.
Bears Say
Order BacklogThe backlog decreased to $14.1M from $19.6M in the previous quarter, caused by booking delays and a one-time cleanup.
ProfitabilityAdjusted EBITDA was $4.1M, falling short of analyst estimates of $4.9M and consensus of $4.3M.
Revenue PerformanceSLP reported revenue of $18.7M, which missed both analyst estimates and consensus expectations of $19.7M.
---
Ownership Overview
18.12% Insiders
24.62% Mutual Funds
21.76% Other Institutional Investors
17.76% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SLP FAQ
What was Simulations Plus’s price range in the past 12 months?
Simulations Plus lowest stock price was $27.22 and its highest was $51.22 in the past 12 months.
What is Simulations Plus’s market cap?
Currently, no data Available
When is Simulations Plus’s upcoming earnings report date?
Simulations Plus’s upcoming earnings report date is Jan 08, 2025 which is in 48 days.
How were Simulations Plus’s earnings last quarter?
Simulations Plus released its earnings results on Oct 23, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.049 by $0.011.
Is Simulations Plus overvalued?
According to Wall Street analysts Simulations Plus’s price is currently Undervalued.
Does Simulations Plus pay dividends?
Simulations Plus pays a Quarterly dividend of $0.06 which represents an annual dividend yield of 0.78%. See more information on Simulations Plus dividends here
What is Simulations Plus’s EPS estimate?
Simulations Plus’s EPS estimate is $0.12.
How many shares outstanding does Simulations Plus have?
Simulations Plus has 20,067,184 shares outstanding.
What happened to Simulations Plus’s price movement after its last earnings report?
Simulations Plus reported an EPS of $0.06 in its last earnings report, beating expectations of $0.049. Following the earnings report the stock price went down -8.888%.
Which hedge fund is a major shareholder of Simulations Plus?
Among the largest hedge funds holding Simulations Plus’s share is Royce & Associates LLC. It holds Simulations Plus’s shares valued at 9M.
---
Simulations Plus Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$57.00 (78.52% Upside)
$57.00 (78.52% Upside)
Blogger Sentiment
Bullish
SLP Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 6.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 9.9%
Last 30 Days ▲ 9.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.44%
12-Months-Change
Fundamentals
Return on Equity
5.65%
Trailing 12-Months
Asset Growth
7.78%
Trailing 12-Months
Company Description
Simulations Plus
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.
---
SLP Company Deck
---
SLP Earnings Call
Q4 2024
0:00 / 0:00
---
SLP Stock 12 Month Forecast
Average Price Target
$57.00
▲(78.52% Upside)
Technical Analysis
Best Analysts Covering SLP
1 Year
1 Year Success Rate
8/20 ratings generated profit
1 Year Average Return
-1.00%
reiterated a buy rating 29 days ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -1.00% per trade.
---